Braxton L. Jamison

CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse

Rocky L. Baker, Braxton L. Jamison, Timothy A. Wiles et al. · Diabetes · 2018 · 65 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immunology +26

Nanoparticles Containing an Insulin–ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells

Braxton L. Jamison, Tobias Neef, Andrew Goodspeed et al. · The Journal of Immunology · 2019 · 64 citations · Full text

Engineering, Immune Regulation, Immunology +22

Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse

Braxton L. Jamison, James E. DiLisio, K. Scott Beard et al. · Diabetes · 2022 · 16 citations · Full text

Engineering, T-regulatory Cell, Immunology +28

An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy

Braxton L. Jamison, Matthew Lawrance, Chun Jing Wang et al. · Cell Reports · 2024 · 14 citations · Full text

In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific Immunotherapy

Minh N. Pham, Liliane Khoryati, Braxton L. Jamison et al. · ImmunoHorizons · 2021 · 10 citations · Full text